Kanzo and Rabeprazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Kanzo (licorice) and Rabeprazole (rabeprazole sodium). Common drug interactions include ascites among females and abdominal distension among males.

The phase IV clinical study analyzes what interactions people have when they take Kanzo and Rabeprazole. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Kanzo?

Kanzo has active ingredients of licorice. eHealthMe is studying from 352 Kanzo users. Check the latest studies of Kanzo.

What is Rabeprazole?

Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.

On Jul, 08, 2026

12 people who take Kanzo and Rabeprazole together, and have interactions are studied.

Kanzo and Rabeprazole drug interactions.

What are the common drug interactions of Kanzo and Rabeprazole, by gender? *:

female:

Ascites (accumulation of fluid in the abdominal cavity)
Decreased appetite
Disease progression
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Hypovolaemia (a decreased volume of circulating blood in the body)
Infection
Insomnia (sleeplessness)
Pleural effusion (water on the lungs)
Pseudomembranous colitis (antibiotic-associated diarrhoea (aad), is an infection of the colon)
Weight increased

male:

Abdominal distension
Ascites (accumulation of fluid in the abdominal cavity)
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Hypophagia (reduced food intake)
Hypovolaemia (a decreased volume of circulating blood in the body)
Infection
Nausea (feeling of having an urge to vomit)
Pathogen resistance
Pleural effusion (water on the lungs)
Pseudomembranous colitis (antibiotic-associated diarrhoea (aad), is an infection of the colon)

What are the common drug interactions of Kanzo and Rabeprazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Antiphospholipid syndrome (disorder that manifests clinically as recurrent venous or arterial thrombosis and/or fetal loss)
Cystitis (inflammation of the wall of the bladder)
Mitral valve stenosis (narrowing of mitral valve)
Cardiac failure
Haemorrhoids (a swollen vein or group of veins in the region of the anus)
Hypertension (high blood pressure)
Insomnia (sleeplessness)
Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)

30-39:

n/a

40-49:

Abdominal distension
Ascites (accumulation of fluid in the abdominal cavity)
Azotaemia (excess of urea or other nitrogenous compounds in the blood)
Balance disorder
Decreased appetite
Dehydration (dryness resulting from the removal of water)
Disease progression
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Hypophagia (reduced food intake)
Hypovolaemia (a decreased volume of circulating blood in the body)

50-59:

n/a

60+:

Ascites (accumulation of fluid in the abdominal cavity)
Decreased appetite
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Weight increased
Abdominal distension
Dehydration (dryness resulting from the removal of water)
Muscle spasms (muscle contraction)
Nausea (feeling of having an urge to vomit)
Renal impairment (severely reduced kidney function)
Azotaemia (excess of urea or other nitrogenous compounds in the blood)

What are the existing conditions these people have? *

Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 4 people, 33.33%
Muscle Spasms (muscle contraction): 3 people, 25.00%
High Blood Pressure: 3 people, 25.00%
Hepatic Neoplasm Malignant (liver cancer): 2 people, 16.67%
Urination - Excessive Volume: 1 person, 8.33%
Abdominal Distension: 1 person, 8.33%
Anaemia (lack of blood): 1 person, 8.33%
Back Pain: 1 person, 8.33%
Constipation: 1 person, 8.33%
Disbacteriosis (a condition with microbial imbalances on or inside the body): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Kanzo and Rabeprazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously